Complicated Appendicitis: Clinical Trials

4 trials for Complicated Appendicitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Recruiting 1, Terminated 1

Follow Complicated Appendicitis: new trials by email Literature Review of Complicated Appendicitis trials Research Report on Complicated Appendicitis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics
Oral amoxicillin-clavulanic acid (40mg/kg in 3 times/day; maximum dose 3g/day), Inpatient postpoperative intravenous antibiotic treatment according to the established protocol in each center - Laparoscopic Appendectomy, Complicated Appendicitis
Phase 4RecruitingFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau7722021-04-222026-09-08
Antibiotic Duration in Post-appendectomy Abscess
ampicillin/clavulanate - Complicated Appendicitis, Perforated Appendicitis
Phase 4TerminatedPhoenix Children's Hospital72019-05-012024-03-08
Optimal Care of Complicated Appendicitis
Early Appendectomy, Interval Appendectomy, Antibiotics - Appendicitis, Perforated Appendicitis
Phase 4CompletedUniversity of Michigan402017-06-292023-11-28
Safety and Efficacy of Single Daily Dose of Ceftriaxone and Metronidazole for Treatment of Complicated Appendicitis in Children
ceftriaxone, metronidazole/ampicillin, gentamicin, and metronidazole - Complicated Appendicitis
Phase 4CompletedHaEmek Medical Center, Israel432008-07-012012-09-05

Narrower conditions

Appendicitis (2)

Broader conditions

Cecal Diseases (2)  ·  Digestive System Diseases (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Infections (2)  ·  Intestinal Diseases (2)  ·  Intraabdominal Infections (2)

Interventions

Amoxicillin-Potassium Clavulanate Combination (2)  ·  Ampicillin (2)  ·  Metronidazole (2)  ·  Anti-Bacterial Agents (1)  ·  Ceftriaxone (1)  ·  Ciprofloxacin (1)  ·  Clavulanic Acid (1)  ·  Gentamicins (1)  ·  Piperacillin (1)  ·  Piperacillin, Tazobactam Drug Combination (1)  ·  Tazobactam (1)

Sponsors

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  HaEmek Medical Center, Israel (1)  ·  Phoenix Children's Hospital (1)  ·  University of Michigan (1)

Countries

United States (2)  ·  Israel (1)  ·  Spain (1)

Top investigators

Craig Egan, MD (1)  ·  Maria Jose Martinez-Zapata, MD, PhD (1)  ·  Steven W. Bruch, M.D. (1)

NIH funding

2025 (1)